Clinical data revealed that visfatin is positively correlated with lymph node metastasis of CRC patients, we then investigated the effects of visfatin on the in vitro motility of CRC cells. This evidence concerns the gene NAMPT and metastatic malignant neoplasm in the lymph nodes.